Products

Catalog No	Chemical Name	CAS Number	Purity
2017822	Balamapimod	863029-99-6	98.0%
Balamapimod, also known as MKI-822, is a Ras/Raf/MEK inhibitor. Balamapimod, may be p
17030606	BP-1-102	1334493-07-0	98%
BP-1-102 is a potent, orally bioavailable and selective STAT3 inhibitor. BP-1-102 bin
17030604	BAY-876	1799753-84-6	98%
BAY-876 is a potent and Selective GLUT1 Inhibitor. BAY-876 showed good metabolic stab
17030312	BRD-7552	1137359-47-7	98%
BRD-7552 is a PDX1 transcription factor inducer. It up regulates PDX1 expression in b
17030305	BDA-366	1821496-27-8	98%
BDA-366 is a BCL2-BH4 antagonist. BDA-366 suppresses human myeloma growth. BDA-366 in
17030116	Bimiralisib	1225037-39-7	98%
Bimiralisib, also known as PQR309, is an orally bioavailable pan inhibitor of phospho
17030110	BEC HCl	222638-67-7	98%
BEC, also known as S-(2-boronoethyl)-L-cysteine, is an a slow-binding and competitive
17109003	BGP-15	66611-37-8	98%
BGP-15, is a nicotinic amidoxime derivative with PARP inhibitory activity. It has bee
16122908	Butylphthalide	6066-49-5	98%
Butylphthalide, also known as 3-n-butylphthalide or NBP, is an antioxidant and one of
16122907	Buthionine Sulphoximine	5072-26-4	98%
Buthionine Sulphoximine, also known as NSC-326231, is a gamma-glutamylcysteine synthe
16122906	Brivaracetam	357336-20-0	98%
Brivaracetam, also known as UCB 34714, is a chemical analog of levetiracetam, is a ra
16122905	Brigatinib (AP-26113)	1197953-54-0	98%
Brigatinib, also known as AP-26113, is an orally active, potent and selective Dual AL
16122904	Brevianamide F	38136-70-8	98%
Brevianamide F , also known as cyclo-(L-Trp-L-Pro), belongs to a class of naturally o
16122903	Bohemine	189232-42-6	98%
Bohemine is a potent and selective, cell-permeable, cyclin-dependent kinase (CDK) inh
16122902	BMS-687453	1000998-59-3	98%
BMS-687453 is a potent and selective peroxisome proliferator activated receptor (PPAR
16122901	BML-210	537034-17-6	98%
BML-210, also known as CAY10433, is HDAC inhibitor. BML-210 induces growth inhibition
16122868	BIIB021	848695-25-0	98%
BIIB021, also known as CNF2024, is an orally active, purine-scaffold, small-molecule
16122867	BI605906	960293-88-3	98%
BI605906 is a IKK inhibitor. BI605906 inhibits TNF-dependent IB degradation and expre
16122866	Benzbromarone	3562-84-3	98%
Benzbromarone is a uricosuric agent and non-competitive inhibitor of xanthine oxidase
16122805	BAY-59-3074	406205-74-1	98%
BAY-59-3074 is a novel cannabinoid CB1/CB2 receptor partial agonist with analgesic pr
16122804	Batimastat	130370-60-4	98%
Batimastat (also known as BB-94) is a synthetic matrix metalloproteinase inhibitor th
16122778	BFH772	890128-81-1	98%
BFH772 is a novel potent oral VEGFR2 inhibitor, targeting VEGFR2 kinase with IC50 of
16122776	BI-78D3	883065-90-5	98%
BI-78D3 is a competitive JNK inhibitor with IC50 of 280nM that displays > 100 fold
16122769	BDA-366	1909226-00-1	98%
BDA-366 is a small-molecule Bcl2-BH4 domain antagonist and binds BH4 with high affini
16122742	BI-7273	1883429-21-7	98%
BI-7273 is a potent, selective, and cell-permeable BRD9 BD Inhibitor.
16122740	BI-9564	1883429-22-8	98%
BI-9564 is a selective inhibitor of BRD9 and BRD7 bromodomains with the IC50 of 75 nM
16122733	BAW2881 (NVP-BAW2881)	861875-60-7	98%
BAW2881 (NVP-BAW2881) is a novel vascular endothelial growth factor (VEGF) receptor t
6111507	BMS-983970	1584713-87-0	98%
BMS-983970 is an oral pan-Notch inhibitor for the treatment of cancer.
6111415	BAY-61-3606	648903-57-5	98%
BAY-61-3606 is a potent and selective inhibitor of Syk kinase (Ki = 7.5 nM).
61402	BH3I-1	300817-68-9	98%
BH3I-1 is an inhibitor of Bcl-xL with IC 50 of 293.95 M. BH3I-1 is a cell permeable B